National Cancer Institute

10 та иш

1. Flanvotumab

   National Cancer Institute

   БошқаCancer Immunotherapy and BiomarkersDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000087

2. Anetumab

   National Cancer Institute

   БошқаMyeloproliferative Neoplasms: Diagnosis and TreatmentDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000089

3. Narnatumab

   National Cancer Institute

   БошқаCancer Immunotherapy and BiomarkersDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000090

4. Catumaxomab

   National Cancer Institute

   БошқаMultiple Myeloma Research and TreatmentsDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000091

5. Ombitasvir

   National Cancer Institute

   БошқаSystemic Lupus Erythematosus ResearchDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000092

6. Gerbil Fibrosarcoma

   National Cancer Institute

   БошқаSarcoma Diagnosis and TreatmentDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000093

7. Anetumab Ravtansine

   National Cancer Institute

   БошқаMultiple Myeloma Research and TreatmentsDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000094

8. Ustilago maydis

   National Cancer Institute

   БошқаPlant Disease Resistance and GeneticsDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000095

9. Seribantumab

   National Cancer Institute

   БошқаNeutrophil, Myeloperoxidase and Oxidative MechanismsDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000098

10. Gerbil Fibroma

    National Cancer Institute

    БошқаShoulder and Clavicle InjuriesDefinitions20200 иқтибос

    ABIABI:AkademIndex/openalex/2020.other.000102